CRBU — Caribou Biosciences Share News
0.000.00%
Last trade - 00:00- $57.12m
- -$55.19m
- $11.16m
Caribou Biosciences falls on early-stage cancer therapy data
Brief: Caribou Biosciences Says Expects To Initiate Pivotal Trial For Cb-010 In H2 2025
U.S. RESEARCH ROUNDUP- Crescent Energy, Rockwell Automation, Transdigm Group
Brief: Caribou Biosciences Expands Clinical Development Of CB-010 With FDA Clearance Of IND In Lupus
Brief: Caribou Biosciences Says CB-010 ANTLER Phase 1 Trial Initial Dose Expansion Data And RP2D To Be Disclosed Q2 2024
Brief: Caribou Biosciences Provides Regulatory Update On Cb-010 Pivotal Plan
Brief: Caribou Biosciences Received Notice From AbbVie Manufacturing Management Unlimited That Abbvie Elected To Terminate Collaboration, License Agreement
U.S. RESEARCH ROUNDUP-Paccar, PennyMac Financial Services, Progressive
U.S. STOCKS ON THE MOVE-Canopy Growth, Ero Copper, VerifyMe,
U.S. STOCKS ON THE MOVE-AT&T, Caribou Biosciences, housing stocks
U.S. STOCKS ON THE MOVE-Netflix, Microsoft, AT&T
U.S. STOCKS ON THE MOVE-Activision Blizzard, UnitedHealth Group, Nikola
Caribou Biosciences drops on pricing $125 mln stock offering
Brief: Caribou Biosciences Announces Pricing Of Upsized $125 Million Public Offering
Caribou's cell therapy shows promise in early-stage cancer study
U.S. RESEARCH ROUNDUP- Activision Blizzard, Gentherm, Snap-On
U.S. STOCKS ON THE MOVE-Microsoft, Genius Sports, Thermo Fisher
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Applied Digital, Sweetgreen
Pfizer makes equity investment in Caribou Biosciences